THERAPEUTIC AGENT COMPRISING ANTIBODY CAPABLE OF SPECIFICALLY BINDING TO HUMAN HMGB-1 AS ACTIVE INGREDIENT
    6.
    发明公开
    THERAPEUTIC AGENT COMPRISING ANTIBODY CAPABLE OF SPECIFICALLY BINDING TO HUMAN HMGB-1 AS ACTIVE INGREDIENT 审中-公开
    与抗体特异性结合人HMGB-1作为有效治疗剂

    公开(公告)号:EP2123297A1

    公开(公告)日:2009-11-25

    申请号:EP08711330.4

    申请日:2008-02-15

    摘要: Previously, it was difficult to obtain high-affinity antibodies that specifically bind to HMGB-1 but not to HMGB-2. Under this circumstance, the present inventors successfully obtained antibodies that are more reactive to HMGB-1 than to HMGB-2 by using specific peptides as an antigen. The present inventors also demonstrated that the antibodies had a HMGB-1-neutralizing activity. The present inventors administered the antibodies to amyloidosis model animals, and as a result, successfully demonstrated that the antibodies produced a significant therapeutic effect.

    摘要翻译: 此前,它什么难以获得高亲和力抗体特异性结合做给HMGB-1,但不是HMGB-2。 在这种情况下,本发明人成功地获得的抗体做了比较的反应性通过使用特定的肽作为抗原,以HMGB-1,而不是HMGB-2。 因此实例阐述了本发明人做了抗体具有一个HMGB-1中和活性。 本发明的发明下辖抗体淀粉样变性的动物模型,并作为一个结果,成功实例阐述没有抗体产生显著的治疗效果。